Neurocrine Biosciences
NBIX
#1567
Rank
NZ$22.94 B
Marketcap
NZ$230.16
Share price
0.82%
Change (1 day)
-14.60%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no stock splits for this company